The FDA's Quiet Retreat: Fewer Public Debates Amid Rising Controversy
The Unseen Engine of Medical Progress
A Slower Lane for Innovation? FDA Opts for Standard Review of Moderna's mRNA Flu Shot
Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag
The Weight of Expectation: FDA, Obesity Drugs, and the Uneasy Dance Between Speed and Safety